Laura Chico

Stock Analyst at Wedbush

(3.01)
# 1,318
Out of 4,902 analysts
228
Total ratings
39.87%
Success rate
0.73%
Average return

Stocks Rated by Laura Chico

Ultragenyx Pharmaceutical
Jul 14, 2025
Maintains: Neutral
Price Target: $35$34
Current: $27.65
Upside: +22.97%
Maze Therapeutics
Jul 8, 2025
Initiates: Outperform
Price Target: $17
Current: $16.47
Upside: +3.25%
BioCryst Pharmaceuticals
Jun 30, 2025
Maintains: Outperform
Price Target: $16$18
Current: $8.59
Upside: +109.55%
Larimar Therapeutics
Jun 24, 2025
Maintains: Outperform
Price Target: $17$15
Current: $3.28
Upside: +357.32%
Lennar
Jun 18, 2025
Reiterates: Neutral
Price Target: $130
Current: $109.57
Upside: +18.65%
Biogen
Jun 12, 2025
Reiterates: Neutral
Price Target: $121
Current: $128.10
Upside: -5.54%
Pharvaris
Jun 5, 2025
Reiterates: Outperform
Price Target: $27
Current: $22.81
Upside: +18.37%
Vigil Neuroscience
May 22, 2025
Downgrades: Neutral
Price Target: $13$8
Current: $8.07
Upside: -0.88%
Travere Therapeutics
May 16, 2025
Reiterates: Outperform
Price Target: $30
Current: $16.82
Upside: +78.36%
Gossamer Bio
May 16, 2025
Reiterates: Outperform
Price Target: $4
Current: $1.75
Upside: +128.57%
Maintains: Outperform
Price Target: $18$17
Current: $5.91
Upside: +187.65%
Reiterates: Outperform
Price Target: $17
Current: $9.16
Upside: +85.59%
Reiterates: Neutral
Price Target: $4
Current: $2.96
Upside: +35.14%
Maintains: Outperform
Price Target: $32$30
Current: $14.58
Upside: +105.76%
Maintains: Neutral
Price Target: $34$26
Current: $23.77
Upside: +9.38%
Maintains: Underperform
Price Target: $26$28
Current: $54.45
Upside: -48.58%
Maintains: Outperform
Price Target: $43
Current: $13.82
Upside: +211.14%
Maintains: Outperform
Price Target: $42$43
Current: $18.61
Upside: +131.06%
Maintains: Outperform
Price Target: $4$3
Current: $0.50
Upside: +500.48%
Reiterates: Outperform
Price Target: $36
Current: $19.94
Upside: +80.54%
Maintains: Outperform
Price Target: $27$28
Current: $6.23
Upside: +349.43%
Maintains: Neutral
Price Target: $30$29
Current: $20.17
Upside: +43.78%
Reiterates: Neutral
Price Target: $6
Current: $9.14
Upside: -34.35%
Maintains: Outperform
Price Target: $157$147
Current: $134.77
Upside: +9.07%
Maintains: Outperform
Price Target: $19$12
Current: $1.32
Upside: +809.09%
Maintains: Outperform
Price Target: $50$49
Current: $32.05
Upside: +52.89%
Maintains: Neutral
Price Target: $8$7
Current: $3.24
Upside: +116.05%
Reiterates: Outperform
Price Target: $11
Current: $4.60
Upside: +139.13%
Reiterates: Outperform
Price Target: $42
Current: $17.04
Upside: +146.48%
Reiterates: Outperform
Price Target: $17
Current: $12.22
Upside: +39.12%
Maintains: Outperform
Price Target: $13$11
Current: $0.46
Upside: +2,280.95%
Reiterates: Neutral
Price Target: $5
Current: $4.06
Upside: +23.15%
Initiates: Market Perform
Price Target: n/a
Current: $58.83
Upside: -
Maintains: Outperform
Price Target: $9$5
Current: $2.57
Upside: +94.55%
Downgrades: Neutral
Price Target: $149
Current: $15.01
Upside: +889.34%
Initiates: Outperform
Price Target: $720
Current: $8.54
Upside: +8,330.91%
Initiates: Strong Buy
Price Target: $280
Current: $53.22
Upside: +426.12%